EPISODE · Dec 1, 2022 · 6 MIN
Thursday, December 1, 2022
from The Gist Healthcare Podcast
A new Alzheimer’s drug has shown promise in slowing cognitive decline in Phase 3 clinical trials but concerns remain about its safety. Former MetroHealth CEO Akram Boutros is suing the hospital system and its board of trustees for violating Ohio’s Open Meetings Act--and its own bylaws--when it fired him. And Twitter has quietly stopped enforcing its COVID-19 misinformation policy. That's coming up on today's episode of Gist Healthcare Daily. Hosted on Acast. See acast.com/privacy for more information.
What this episode covers
A new Alzheimer’s drug has shown promise in slowing cognitive decline in Phase 3 clinical trials but concerns remain about its safety. Former MetroHealth CEO Akram Boutros is suing the hospital system and its board of trustees for violating Ohio’s Open Meetings Act--and its own bylaws--when it fired him. And Twitter has quietly stopped enforcing its COVID-19 misinformation policy. That's coming up on today's episode of Gist Healthcare Daily. Hosted on Acast. See acast.com/privacy for more information.
NOW PLAYING
Thursday, December 1, 2022
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m